NRG oncology RTOG 0625: a randomized phase II trial of bevacizumab with either irinotecan or dose-dense temozolomide in recurrent glioblastoma
作者
Mark R. Gilbert,Stephanie L. Pugh,Ken Aldape,A. Gregory Sorensen,Tom Mikkelsen,Marta Peñas-Prado,Felix Bokstein,Young Kwok,R. Jeffrey Lee,Minesh P. Mehta
出处
期刊:Journal of Neuro-oncology [Springer Science+Business Media] 日期:2016-10-21卷期号:131 (1): 193-199被引量:72